SAM #26-005342

Sole Source Maintenance for Illumina NovaSeq X Plus Sequencer at NIH Clinical Center

This notice announces the NIH Clinical Center's intent to award a sole source contract for maintenance of an Illumina NovaSeq X plus sequencer. - Procuring agency: NIH Clinical Center, Department of Laboratory Medicine - Sole source vendor: Illumina, Inc. (5200 Illumina Way, San Diego, CA 92122) - Product/service: Maintenance agreement for Illumina NovaSeq X plus sequencer - Illumina is both the OEM and sole authorized service provider - Procurement method: FAR Part 13 Simplified Acquisition Procedures - Justification: Only the OEM can provide the required maintenance; exemption from competition - No part numbers or quantities specified; service covers ongoing maintenance for a single instrument - Place of performance: NIH Clinical Center, 6707 Democracy Blvd, Suite 106, Bethesda, MD 20892 - Commercial opportunity: Sole source, not open to competition - Key requirements: OEM maintenance, government facility, ongoing service

Relevant Details - No competing vendors or alternative products identified due to OEM exclusivity - No specific period of performance or contract value disclosed

Description

This acquisition is for a maintenance agreement for the Illumina NovaSeq X plus sequencer at the Department of Laboratory Medicine (DLM) at the National Institutes of Health (NIH) Clinical Center (CC).

•             Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies

•             NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing

•             Place of Performance: Bethesda, MD 20892 USA

POTS: 26-005342

Description:

This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a fixed price purchase order to Illumina, Inc., located at 5200 Illumina Way, San Diego, CA 92122, on a firm fixed price sole source award basis to provide maintenance for the Illumina NovaSeq X plus sequencer at the National Institutes of Health DLM.

The instrument is manufactured and serviced by the vendor. Continuation of maintenance is required by the original manufacturer (Illumina, Inc.) and it is therefore deemed to be in the Government’s best interest that this service is procured from them.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by May 5, 2026 at 11am EST.

View original listing